[The frequency of cancer in France in 2006, mortality trends since 1950, incidence trends since 1980 and analysis of the discrepancies between these trends].

Abstract:

:In 2006, a total number of 149,000 cancer deaths were observed in France, 88,500 in the male population and 60,500 in the female population. In 2005, the number of new diagnoses of cancer is estimated to be 319,000, 183,000 among men and 136,000 among women. Age-standardised mortality rates are decreasing for most frequent cancer sites, at least in recent years, the main exceptions being lung in the female population, and pancreas in both male and female populations. Age-standardised incidence rate has increased by 38% between 1980 and 2005, when one takes demographic changes into account. This trend is the consequence of the increase in prostate cancer incidence among men and mostly of the increases in breast and lung cancers incidence, among women.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Guérin S,Doyon F,Hill C

doi

10.1684/bdc.2008.0795

subject

Has Abstract

pub_date

2009-01-01 00:00:00

pages

51-7

issue

1

eissn

0007-4551

issn

1769-6917

pii

bdc.2008.0795

journal_volume

96

pub_type

杂志文章
  • [WHO classification of head and neck tumours 2017: Main novelties and update of diagnostic methods].

    abstract::The publication of the new WHO classification of head and neck tumours in 2017 brought major modifications. Especially, a new chapter is dedicated to the oropharynx, focusing on the description of squamous cell carcinoma induced by the virus Human Papilloma Virus (HPV), and new entities of tumors are described in nasa...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.04.004

    authors: Sarradin V,Siegfried A,Uro-Coste E,Delord JP

    更新日期:2018-06-01 00:00:00

  • [Oxaliplatin in combination with 5-fluoro-uracil and folinic acid as treatment of metastatic colorectal cancer].

    abstract::Unusual aspect of the development of oxaliplatin was that substantial evidence of its activity was gathered when used in combination with protracted infusion of 5FU combined with leucovorin, preceeding the formal demonstration of its single activity in this disease. Phase II trials in previously treated patients by 5F...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: André T,Louvet C,Maindrault-Goebel F,Gramont AD

    更新日期:2001-08-01 00:00:00

  • [The value of MRI in the diagnosis of joint involvement in malignant primitive tumors of the knee].

    abstract:INTRODUCTION:Surgical treatment of malignant primitive tumors of bone needs a precise preoperative assessment of tumor local extension. Joint involvement (JI) represents the most important finding to determine, for the choice of surgical procedure (intra- or extra-articular resection). OBJECTIVE:To determine the value...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.bulcan.2016.09.018

    authors: Chelli Bouaziz M,Riahi H,Mechri M,Abid L,Rafaa M,Ladeb MF

    更新日期:2016-11-01 00:00:00

  • [Management of side effects of targeted therapies in renal cancer: iatrogenic side effects].

    abstract::Since premedication of patients with an H1 antihistamine is recommended before the start of the intravenous infusion of temsirolimus, temsirolimus is to be used with caution in cases where there is a history of hypersensitivity to this class of antihistamines, or medical contra-indication for treatment with antihistam...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2011.1447

    authors: Massard C,Patard JJ,Hermine O,Ravaud A

    更新日期:2011-01-01 00:00:00

  • [Ten years of advances in head and neck surgery, how does this influence postoperative radiotherapy?]

    abstract::Minimal invasive surgery and reconstructive surgery tend to become the standard in France in the management of head and neck tumors. The use of endoscopic approaches (through endoscopic endonasal/transoral approaches±robot-assisted) instead of open surgery and the use of reconstructive surgery using autologous (flaps)...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2020.04.011

    authors: Thariat J,Leleu T,Micault E,Gery B,Bastit V,Jeanne C,Humbert M,Dugas A,Le Guevelou J,Florescu C,Patron V,Lasne-Cardon A,Babin E

    更新日期:2020-01-01 00:00:00

  • [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].

    abstract::The biological behaviour of invasive carcinoma of the uterine cervix is not always predictable. It is therefore important to establish new biological markers which could be useful in determining a more reliable prognosis. We have analyzed the c-Ha-ras and c-myc proto-oncogenes in a large series (154 cases) of cervical...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Riou G,Sheng ZM,Zhou D,Lusinchi A,Le Doussal V,Barrois M

    更新日期:1990-01-01 00:00:00

  • [Hepatocellular carcinoma: Increase in incidence or future plague?]

    abstract::Hepatocellular carcinoma is the third most frequent cause of cancer death worldwide, particularly in Asia and Africa. Most cases complicate an underlying liver cirrhosis due to hepatitis B or C chronic virus infection or alcoholic abuse. But, following the current epidemics of obesity and type 2 diabetes, it appears t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.02.003

    authors: Raoul JL,Raimbourg J,Hiret S,Adhoute X,Senellart H

    更新日期:2018-05-01 00:00:00

  • [New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "à la carte" treatment?].

    abstract::This review reports 3 of recently published molecular classifications of the 3 main gastro-intestinal cancers: gastric, pancreatic and colorectal adenocarcinoma. In colorectal adenocarcinoma, 6 independent classifications were combined to finally hold 4 molecular sub-groups, Consensus Molecular Subtypes (CMS 1-4), lin...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.05.007

    authors: Dreyer C,Afchain P,Trouilloud I,André T

    更新日期:2016-07-01 00:00:00

  • Herpes virus production as a marker of repair in ultraviolet irradiated human skin cells of different origin.

    abstract::When confluent human skin cultures are ultraviolet (UV)-irradiated before infection with Herpes Simplex type 1 virus (HSV), their capacity to support virus growth is impaired. When the time interval between UV-exposure and infection is increased up to 36 hours, different recoveries of HSV production capacity are obser...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Coppey J,Moreno G,Nocentini S

    更新日期:1978-01-01 00:00:00

  • [Checkpoint inhibitors-induced hypophysitis].

    abstract::Checkpoint inhibitors immunotherapy is more and more prescribed in oncology, causing new immune related endocrine adverse events. Hypophysitis occurs in approximately 10 % of patients treated with anti-CTLA4. It occurs two to three months after initiation of the immunotherapy. The initial presentation is characterized...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2020.01.012

    authors: du Payrat JA,Cugnet-Anceau C,Maillet D,Levy M,Raverot G,Disse E,Borson-Chazot F

    更新日期:2020-04-01 00:00:00

  • ARLTS1, potential candidate gene in familial aggregation of hematological malignancies.

    abstract:INTRODUCTION:Genetic predisposition to familial hematological malignancies was previously described through several epidemiological analyses, but the genetic basis remains unclear. The tumor-suppressor ARLTS1 gene was previously described in sporadic hematological malignancies and familial cancer context. METHODS:In t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.10.016

    authors: Hamadou WS,Besbes S,Mani R,Bourdon V,Ben Youssef Y,Achour B,Regaieg H,Eisinger F,Mari V,Gesta P,Dreyfus H,Bonadona V,Dugast C,Zattara H,Faivre L,Noguchi T,Khélif A,Sobol H,Soua Z

    更新日期:2017-02-01 00:00:00

  • [Multiple brain metastases after breast cancer and their radiotherapy management: what is the optimal treatment?].

    abstract::Whole brain radiotherapy remains standard in the management of breast cancer patients with brain metastases. It allows for symptomatic improvement and good local control in most patients. However, its results remain suboptimal in terms of both efficacy and toxicity. In highly selected patients, stereotactic radiothera...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1335

    authors: Kirova YM,Chargari C,Mazeron JJ

    更新日期:2011-04-01 00:00:00

  • [Acute cerebellar syndrome after treatment with 5-fluorouracil].

    abstract::We report on a case of 5-fluorouracil induced neurotoxicity during 5-fluorouracil cisplatin combination chemotherapy for advanced head and neck squamous cell carcinoma. The initial manifestations included an acute cerebellar syndrome and peripheral neuropathy. Computed tomography of the brain was normal. The results o...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Barbieux C,Patri B,Cerf I,de Parades V

    更新日期:1996-01-01 00:00:00

  • [Current views in geriatric oncology].

    abstract::Geriatric oncology represents a novel specialty which can be defined as specific older cancer patients management. It includes a validated geriatric procedure, the comprehensive geriatric assessment, which is the best way of approaching the complex interacting medical problems of frail older patients. Geriatric assess...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Terret C,Gaujard S,Droz JP

    更新日期:2003-01-01 00:00:00

  • [Treatment of chronic myeloid leukemia in 2007].

    abstract::The treatment of chronic myeloid leukemia (CML) has considerably evolved since imatinib mesylate has been introduced as a new therapeutic weapon for this disease. The 5-year updated results of the IRIS study confirmed that imatinib mesylate is the best first line therapy for chronic phase CML with an overall survival ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Labussière H,Hayette S,Tigaud I,Michallet M,Nicolini FE

    更新日期:2007-10-01 00:00:00

  • 4-methylthio 2-oxobutanoate transaminase: a specific target for antiproliferative agents.

    abstract::We have previously shown that the addition of 4-methylthio-2-oxobutanoate (MTOB) to cultures of methionine dependent neoplastic cells which lack endogenous MTOB restores their capacity to grow in the absence of exogenous methionine. Transition state inhibitors of the MTOB transaminase,responsible for the transaminatio...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Quash G,Roch AM,Charlot C,Chantepie J,Thomas V,Hamedi-Sangsari F,Vila J

    更新日期:2004-04-01 00:00:00

  • [Gemtuzumab ozogamicin for treatment of acute myeloid leukemia].

    abstract::Gemtuzumab ozogamicin (GO) is a humanized monoclonal antibody anti-CD33 conjugated with calicheamicin and was indicated for acute myeloid leukemia (AML) patients. It was initially approved in 2000 by FDA thank to promising results from a phase II trial including elderly relapsing AML patients. Numerous studies evaluat...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2014.1886

    authors: Brotelle T,Lemal R,Moluçon-Chabrot C,Bay JO,Delaunay J,Guièze R

    更新日期:2014-02-01 00:00:00

  • [Hospital teaching of oncology].

    abstract::Theoretical teaching of oncology was improved, 15 years ago, by individualizing a special university course during medical studies in France. However medical students need also practical exercising by relation with cancer patients. The main goals may be defined and given to students at the beginning of practical cours...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hoerni B,Vrousos C

    更新日期:1985-01-01 00:00:00

  • [Rational choice of a diagnostic test for the detection of bone metastases in breast cancer as a function of prevalence (based on the Bayes theorem)].

    abstract::Since 1976 to 1978 inclusive, 465 patients with primary breast cancers underwent whole body analogical scintiscans, 456 numerical scans, and 453 were X-rayed. Ninety per cent received axillary node ablation, 62% presented adenopathies of which a third were capsular ruptures and 54% were T3 and T4. In 53 patients, the ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Robillard J,Ly Van Hoa,Switzers O,Couette JE,Brune D

    更新日期:1987-01-01 00:00:00

  • [Larynx cancer in France: descriptive epidemiology and incidence estimation].

    abstract::The epidemiology of cancers is known in France through mortality data provided by Inserm and morbidity data obtained by French tumor registries. The purpose of this study was to compare the incidence of laryngeal cancers in 9 French departments and to give an estimate of this incidence for the whole of France, based o...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Peng J,Ménégoz F,Lesec'h JM,Remontet L,Grosclaude P,Buémi A,Guizard AV,Tretarre B,Danzon A,Velten M,Maarouf N,Jougla E,Launoy G,Dubreuil A

    更新日期:2004-04-01 00:00:00

  • [Unresolved questions in the indications for the conservative treatment of invasive cancer of the breast].

    abstract::The majority of patients with breast cancer can be treated by partial mastectomy and radiation therapy. The choice of the treatment involves the estimation of the risk for intramammary recurrence and the ability to achieve satisfactory cosmetic result. Patient selection in breast conserving therapy is dependent on cli...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Zinzindohoué C,Bobin JY

    更新日期:1998-09-01 00:00:00

  • [Role of the epithelial-mesenchymal transition during tumor progression].

    abstract::The epithelial-mesenchymal transition (EMT) is a morphogenetic program that converts epithelial into mesenchymal cells during the embryonic development. This mechanism is frequently reactivated during tumor progression and provides cells with motility and invasive capabilities favoring the metastatic dissemination fro...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2009.1025

    authors: Ansieau S,Caron de Fromentel C,Bastid J,Morel AP,Puisieux A

    更新日期:2010-01-01 00:00:00

  • [Radioimmunotargeting: diagnosis and therapeutic use].

    abstract::Monoclonal antibodies labeled with a radionuclide make feasible the in vivo radioimmunotargeting of tumor cells. This targeting could be performed for diagnosis, using gamma emitters, or for therapeutic purpose when antibodies are labeled with beta- and in the future alpha-emitters. Diagnosis applications (tumor detec...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Vuillez JP

    更新日期:2000-11-01 00:00:00

  • [Breast cancer management before 40 years: what change in one decade? A retrospective study at the "Institut de cancérologie de Lorraine": 2002-2012].

    abstract:INTRODUCTION:Breast cancer of young women has medico-psychological issues, particularly in the perspective of "after cancer" period. The objective of the study was to analyze the changes in management, in a decade including the publication of Cancer Plans I and II. METHODS:This retrospective unicentric study involved ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/S0007-4551(20)30049-7

    authors: Soussoko M,Salleron J,Desandes E,Lesur A

    更新日期:2019-12-01 00:00:00

  • [External beam radiation therapy and interstitial brachytherapy in the treatment of anal canal carcinomas: a series of 70 patients].

    abstract::This study is concerning 70 patients (57 female, 13 male) with an epidermoid carcinoma of the anal canal which were treated homogeneously with a combination of an external beam radiation therapy ((45 Gy in 25 fractions of 1.8 Gy for 5 weeks) and a brachytherapy with Iridium wires (15 to 20 Gy delivered to the gross re...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Dubois JB,Azria D,Ychou M

    更新日期:2003-12-01 00:00:00

  • [Prostate cancer: update].

    abstract::The study of mitotic transduction of the signal showed that overexpression of pAkt and reduction in pERK expression would be associated a biological relapse. For tumors T1-3 N0M0 at the high risk of local relapse after prostatectomy, an immediate radiotherapy compared with a differed radiotherapy (at the time of PSA r...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Oudard S,Medioni J,Scotté F,Banu E

    更新日期:2005-10-01 00:00:00

  • [Evaluation of professional practices: improving cancer related-pain management in radiation oncology].

    abstract::Radiation oncologist often faced cancer pain, regardless the stage of cancer. Given the high prevalence of cancer pain, and its potential for profound adverse consequences, all patients with active malignancy should be routinely screened and treated for pain. Using a questionnaire developed by the pain center of the I...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2012.1630

    authors: Auberdiac P,Levy A,Guy JB,Malkoun N,Moncharmont C,Chargari C,Michaud P,De Laroche G,Magné N

    更新日期:2012-09-01 00:00:00

  • [Radioimmunotherapy of follicular lymphoma: a step towards cure?].

    abstract::Advanced stage follicular lymphoma is incurable by conventional treatment. Important progress has been observed with the development of new therapies based on monoclonal antibodies and on the use of radioimmunotherapy (RIT) in the treatment of non-Hodgkin lymphomas (NHL). Rituximab in combination with chemotherapy in ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Ketterer N,Bischof Delaloye A,Helg C,Luthi F,Buchegger F

    更新日期:2007-09-01 00:00:00

  • A phase I-II, dose-escalating trial of ZD9331 in combination with irinotecan (CPT11) in previously pretreated metastatic colorectal cancer patients.

    abstract:BACKGROUND:To establish the recommended dose (RD) of the thymidylate-synthase inhibitor ZD9331 administered with irinotecan (CPT-11) in patients with pretreated metastatic colorectal cancer, and to assess toxicity profile, pharmacokinetics (PK), and anti-tumor activity in a phase I/II open, multicenter, intrapatient ch...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Louvet C,André T,Gamelin E,Garcia ML,Saavedra A,Lenaers G,de Gramont A,Méry-Mignard D,Kalla S

    更新日期:2004-12-01 00:00:00

  • [Supportive care for survivors].

    abstract::Advances in early detection and treatment have pushed in a few decades the management of cancers from a management model of the end of life to the management of a chronic disease. This evolution has accelerated the development of supportive care in two directions, firstly towards the best possible support to the end o...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.04.007

    authors: Ninot G,Debourdeau P,Blanc-Legier F,De Crozals F,De Rauglaudre G,Khouri S,Kirscher S,Mineur L,Piollet I,Sant I,Schillinger P,Serin D

    更新日期:2018-09-01 00:00:00